Items where authors include "Schuh, A."

Article

Munir, T., Cairns, D.A. orcid.org/0000-0002-2338-0179, Bloor, A. et al. (29 more authors) (2023) Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease. New England Journal of Medicine. ISSN 0028-4793

Alaggio, R. orcid.org/0000-0003-3915-3816, Amador, C. orcid.org/0000-0003-0352-5526, Anagnostopoulos, I. orcid.org/0000-0002-5043-6043 et al. (307 more authors) (2023) Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748. Leukemia, 37 (9). pp. 1944-1951. ISSN 0887-6924

Hillmen, P., Pitchford, A., Bloor, A. et al. (29 more authors) (2023) Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial. Lancet Oncology, 24 (5). pp. 535-552. ISSN 1470-2045

Robbe, P. orcid.org/0000-0002-0691-1126, Ridout, K.E., Vavoulis, D.V. orcid.org/0000-0002-3984-1507 et al. (142 more authors) (2022) Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. Nature Genetics, 54. pp. 1675-1689. ISSN 1061-4036

Xiao, Q., Stewart, N.J. orcid.org/0000-0001-8358-394X, Willmering, M.M. et al. (9 more authors) (2021) Human upper-airway respiratory airflow: In vivo comparison of computational fluid dynamics simulations and hyperpolarized 129Xe phase contrast MRI velocimetry. PLoS ONE, 16 (8). e0256460. ISSN 1932-6203